A novel protein that participates in nonself discrimination of malignant cells by homologous complement

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1266-1270

  Matsumoto, Misako ^a   Takeda, Junji ^b   Inoue, Norimitsu ^b   Hara, Tomoko ^a   Hatanaka, Michiyo ^a   Takahashi, Kazuhiko ^c   Nagasawa, Shigeharu ^c   Akedo, Hitoshi ^a   Seya, Tsukasa ^a,d  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CANCER CELL; COMPLEMENT SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; TUMOR IMMUNOLOGY; XENOGRAFT;

EID: 0030724697     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1266     Document Type: Article

References (19)

1. Janeway, C.A., Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11-16 (1992).
2. Atkinson, J.P. & Farris, T.C. Separation of self from nonself in the complement system. Immunol. Today 8, 212-213 (1987).
3. Ramos, O. F., Sarmay, G., Klein, E., Yefenof, E. & Gergely, J. Complement-dependent cellular cytotoxicity: Lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum. Proc. Natl. Acad. Sci. USA 82, 5470-5474 (1985).
4. Seya, T., Kara, T., Matsumoto, M. & Akedo, H. Quantitative analysis of membrane cofactor protein (MCP) of complement: High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J. Immunol. 145, 238-245 (1990).
5. Matsui, H., Tsuji, S., Nishimura, H., & Nagasawa, S. Activation of the alternative pathway of complement by apoptotic Jurkat cells. FEBS lett. 351, 419-422 (1994).
6. Matsumoto, M. & Seya, T. Homologous C3 deposition and homotypic cell adhesion in a human myeloid cell line, P39. Eur. J. Immunol. 23, 2270-2278 (1993).
7. Matsumoto, M., Yamashita, F., Iida, K., Tomita, M. & Seya, T. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3. J. Exp. Med. 181, 115-125 (1995).
8. Low, S.C. & Berry, M.J. Knowing when not to stop: Selenocysteine incorporation in eukaryotes. Trends Biochem. Sci. 21, 203-208 (1996).
9. Hill, K.E., Lloyd, R.S., Yang, J.-G., Read, R. & Burk, R.F. The cDNA for rat selenoprotein P contains 10 TGA codons in the open reading frame. J. Biol. Chem. 266, 10050-10053 (1991).
10. Dempsey, P.W., Allison, M.E.D., Akkaraju, S., Goodnow, C.C. & Fearon, D.T. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271, 348-350 (1996).
11. Fearon, D.T. & Locksley, R.M. The instructive role of innate immunity in the acquired immune response. Science 272, 50-54 (1996).
12. Karp, C.L. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231 (1996).
13. Holmskov, U., Malhotra, R., Sim, R.B. & Jensenius, J.C. Collectins: Collagenous C-type lectins of the innate immune defense system. Immunol. Today 15, 67-74 (1994).
14. Umemura, K., Yokota, Y., Kozutsumi, Y. & Kawasaki, T. A unique CD45 glycoform recognized by the serum mannan-binding protein in immature thymocytes. J. Biol. Chem. 271, 4581-4584 (1996).
15. Gladyshev, V.N., Jeang, K.-T. & Stadtman, T.C. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA 93, 6146-6151 (1996).
16. Itoh, N. et al. Cloning of an interleukin-3 receptor gene: A member of a distinct receptor gene family. Science 247, 324-327 (1990).
17. Matsumoto, M., Seya, T., & Nagasawa, S. Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. Biochem. J. 281, 493-499 (1992).
18. Kikkawa, S., Matsumoto, M., & Seya, T. Development of monoclonal antibodies against homologous C3 activating molecule, M161Ag. Jpn. Biochem. Soc. 68, 703 (1996) (Abstr.).
19. Iwai, K. et al. Preparation of a verifiable peptide-protein immunogen: Direction-controlled conjugation of a synthetic fragment of the monitor peptide with myoglobin and application for sequence analysis. Anal. Biochem. 171, 277-282 (1988).